Table 1 Clinical parameters of the study population
Revascularization (n = 128) | No (n = 312) | p | |
|---|---|---|---|
Age (years) | 61.1 ± 9.4 | 60.0 ± 10.5 | 0.337 |
Male gender | 88 (69%) | 161 (52%) | 0.001 |
Systolic blood pressure (mmHg) | 123.6 ± 14.2 | 121.1 ± 15.4 | 0.126 |
Diastolic blood pressure | 74.4 ± 9.5 | 73.5 ± 9.9 | 0.385 |
Heart rate (bpm) | 66.7 ± 11.2 | 66.4 ± 12.4 | 0.809 |
Body mass index (kg/m2) | 24.8 ± 3.4 | 25.2 ± 3.2 | 0.226 |
Hypertension | 69 (54%) | 140 (45%) | 0.093 |
Diabetes | 34 (27%) | 54 (17%) | 0.035 |
Stroke | 5 (4%) | 16 (5%) | 0.806 |
Current smoker | 40 (31%) | 68 (22%) | 0.051 |
Medications | |||
RASB | 38 (30%) | 82 (27%) | 0.410 |
CCB | 31 (25%) | 74 (24%) | 0.902 |
Statin | 40 (32%) | 84 (27%) | 0.350 |
Aspirin | 36 (29%) | 67 (21%) | 0.135 |
Clopidogrel | 10 (7%) | 14 (5%) | 0.167 |
Diuretics | 9 (7%) | 28 (9%) | 0.704 |
Beta-blocker | 17 (14%) | 32 (10%) | 0.402 |
Trimetazidine | 14 (11%) | 19 (6%) | 0.075 |